Has Ramsudha Narala, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,592 in general payments to Ramsudha Narala, MD across 22 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ramsudha Narala, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ramsudha Narala, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ramsudha Narala, MD

Retina Specialist · Stanford, CANPI 1093058323

Payments from drug & device makers

$2,592in general payments, 2019–2025

Across 22 payments — averaging $117.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Dutch Ophthalmic, USA$840
Alimera Sciences, Inc.$577
Regeneron Healthcare Solutions, Inc.$251
Bausch & Lomb, A Division Of Bausch Health US, LLC$250
Novartis$244
Amgen$217
plus $213 from 4 others

What the payments were for

Travel & lodging$84032%
Food & beverage$1,75268%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Dutch Ophthalmic, USA	1	$840
Alimera Sciences, Inc.	6	$577
Regeneron Healthcare Solutions, Inc.	4	$251
Bausch & Lomb, A Division Of Bausch Health US, LLC	2	$250
Novartis	2	$244
Amgen	2	$217
Genentech, Inc.	1	$120
AbbVie	2	$37
Astellas Pharma Global Development	1	$33
Alcon	1	$23

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,592 in reported general payments places this provider in the 35th percentile of 187 retina specialist providers in California.

See all retina specialist providers in California →

Medicare billing

Part B allowed, 2024

$70,451

Medicare patients

200

Services billed

922

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Prednisolone Acetate	24	$734
Timolol Maleate	21	$236
Brimonidine Tartrate	15	$233
Latanoprost	13	$137

Paid to pharmacies, not to this prescriber.

Other retina specialist in Stanford

Ehsan RahimyStanford$1.5M
Diana DoStanford$465K
Prithvi MruthyunjayaStanford$444K
Theodore LengStanford$308K
Mary HartnettStanford$89K
Charles DeboerStanford$79K
Dante PieramiciSanta Barbara$15.1M
Margaret ChangSacramento$13.2M
Hani Salehi-HadHuntington Beach$12.2M
Payam AminiPasadena$9.9M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →